Study of Recombinant Human Thrombin for Bleeding During Autologous Skin Grafting

Completed · Phase 2

Conditions studied: Surgical Hemostasis

In brief

The purpose of this study is to evaluate whether rThrombin is safe when used for controlling bleeding during skin graft surgery.

Key facts

Study ID

NCT00371215

Run by

ZymoGenetics

People needed

72

Starts

2006-08-01

Expected to finish

2007-06-01

Last updated by the study team

2009-03-09

Who can join

Age: 2 and older, up to 75. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Autologous skin grafting with sheet or mesh grafts following burn or traumatic skin injury

You may not qualify if…

• Known antibodies or hypersensitivity to thrombin or other coagulation factors

Where it is running

• Richard M. Fairbanks Burn Center, Wishard Hospital — Indianapolis, Indiana, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.